ArticleInternational journal of surgery case reports2025
Epithelial-myoepithelial carcinoma of the parotid gland: Case report.
Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Regulating the dormancy of cancer stem cells: a novel approach to preventing cancer relapse.Cell death & disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and importanceMalignant salivary gland neoplasms present a significant diagnostic challenge, requiring the integration of clinical, radiological, and pathological assessments. Epithelial-myoepithelial carcinoma (EMC) is a rare malignant neoplasm that exhibits a biphasic histopathological pattern. Although the major salivary glands are most commonly affected, EMC can also involve minor salivary glands and, in rare instances, the seromucous glands of the upper aerodigestive tract. PRESENTATION OF CASE: A 47-year-old male presented with a right-sided parotid mass. On physical examination, a solitary, well-defined, nodular mass, approximately 3 cm in size, was palpated in the right parotid gland, demonstrating mobility. Fine-needle aspiration biopsy indicated a cystic lesion. A right superficial parotidectomy was performed with careful preservation of the facial nerve. The tumor was managed with surgery alone, with negative surgical margins. The patient had no recurrence at the 3-year follow-up. CLINICAL DISCUSSION: Tumors with features such as positive surgical margins, aneuploidy, nuclear atypia, solid growth pattern, increased mitotic activity, and necrosis are indicative of more aggressive behavior in EMC. Despite being classified as low-grade tumors, EMC has been associated with local recurrence and distant metastasis. In cases exhibiting aggressive characteristics, surgery alone may be insufficient, necessitating the addition of elective neck irradiation to prevent local recurrences. Achieving tumor-negative surgical margins is considered critical for reducing the likelihood of recurrence.
conclusionEMC is a rare salivary gland malignancy that requires careful diagnostic evaluation and management. While surgery alone may be sufficient for certain cases with negative surgical margins, further treatment such as irradiation may be warranted in aggressive cases to minimize recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.